Old National Bancorp Grifols Sa Transaction History

Old National Bancorp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 21, 2021	SELL	$15.15 - $19.78 $152,348 - $198,907	-10,056 Closed	0 $0
Q4 2020 Jan 19, 2021	SELL	$16.86 - $19.67 $8,008 - $9,343	-475 Reduced 4.51%	10,056 $185,000
Q3 2020 Oct 29, 2020	BUY	$15.4 - $20.16 $162,177 - $212,304	10,531 New	10,531 $183,000
Q1 2020 Apr 24, 2020	SELL	$16.28 - $25.63 $174,505 - $274,727	-10,719 Closed	0 $0
Q4 2019 Jan 16, 2020	SELL	$19.57 - $23.52 $28,356 - $34,080	-1,449 Reduced 11.91%	10,719 $250,000
Q3 2019 Oct 22, 2019	BUY	$19.85 - $22.76 $4,466 - $5,121	225 Added 1.88%	12,168 $244,000
Q2 2019 Jul 15, 2019	SELL	$17.59 - $21.1 $6,314 - $7,574	-359 Reduced 2.92%	11,943 $252,000
Q1 2019 Apr 30, 2019	BUY	$18.01 - $20.11 $1,080 - $1,206	60 Added 0.49%	12,302 $247,000
Q4 2018 Jan 31, 2019	SELL	$17.44 - $21.53 $13,986 - $17,267	-802 Reduced 6.15%	12,242 $225,000
Q3 2018 Oct 26, 2018	SELL	$19.97 - $21.96 $7,209 - $7,927	-361 Reduced 2.69%	13,044 $279,000
Q2 2018 Jul 26, 2018	BUY	$20.16 - $24.68 $270,244 - $330,835	13,405 New	13,405 $288,000

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $4.91B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Old National Bancorp , based on Form 13F filings with the SEC.

Stay updated on Old National Bancorp with notifications on news.